Experiment 960696

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismTripterygium wilfordii (CELASTRACEAE)
CitationTAO,XL: SHI,YP: CHEN,XH: ZHANG,NZ:. (1988). TREATMENT OF RHEUMATOID ARTHRITIS WITH THE POLYGLYCOSIDES OF TRIPTERYGIUM WILFORDII. I. EFFECT ON THE PRODUCTION OF IGM AND IGM-RF BY PERIPHERAL BLOOD MONONUCLEAR CELLS(PBMC).. 10(5)
Amount utilized
Compound isolated
DiseaseTHE TOTAL IGM AND IGM-RF PRODUCED BY PBMC IN VITRO WERE DETERMINED IN 56 CASES OF RHEUMATOID ARTHRITIS AND 24 NORMAL HEALTHY PERSONS. PATIENTS WITH RHEUMATOID ARTHRITIS WERE FOUND TO HAVE HIGHER IGM-RF AND IGM-RF/IGM RATIO BUT SIMILAR TOTAL IGM. IN A DOUBLE-BLIND CLINICAL TRIAL, ADMINISTRATION OF THE "POLYGLYCOSIDES" OF TRIPTERYGIUM WILFORDII FOR 3 MONTHS RESULTED IN A SIGNIFICANT INHIBITION OF PRODUCTION OF TOTAL IGM AND IGM-RF BY PBMC IN RHEUMATOID ARTHRITIS IN VITRO. BUT, THE IGM-RF/IGM RATIO WAS NOT AFFECTED. THE "POLYGLYCOSIDE" WAS ALSO FOUND TO INHIBIT THE SYNTHESIS OF TOTAL IGM AND IGM-RF INDUCED BY PHYTOLACCANINE. THE RESULTS SUGGESTED THAT THE THERAPEUTIC MECHANISM OF THE "POLYGLYCOSIDE" WAS VIA ITS IMMUNOMODULATORY ACTION ON PBMC.
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE
ExtractCHROMATOGRAPHIC FRACTION